Close Menu

SAN FRANCISCO (GenomeWeb) – NanoString highlighted the promise of its upcoming technologies as well as its progress in the oncology field at the JP Morgan Healthcare Conference held here this week.

With an eye on the future, CEO Brad Gray said the firm expects its upcoming Digital Spatial Profiling and Hyb & Seq technologies to make major dents in biology and the clinical sequencing markets.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.